Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.
Kroll JL, Beam C, Li S, Viscidi R, Dighero B, Cho A, Boulware D, Pescovitz M, Weinberg A. Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes. J Clin Virol. 2013 Jun; 57(2):115-9.